(DAR) Darling Ingredients - Overview
Stock: Collagen, Fats, Proteins, Fertilizer, Biofuel
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 40.6% |
| Relative Tail Risk | -7.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 18.63 |
| Character TTM | |
|---|---|
| Beta | 0.950 |
| Beta Downside | 1.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.42% |
| CAGR/Max DD | -0.16 |
Description: DAR Darling Ingredients January 09, 2026
Darling Ingredients Inc. (NYSE:DAR) converts edible and inedible bio-nutrients into a portfolio of natural ingredients across three segments-Feed, Food, and Fuel-serving pharmaceutical, pet-food, feed, industrial, bio-energy, and fertilizer markets worldwide. The business model hinges on collecting animal by-products, used cooking oil, and bakery waste, then processing them into collagen, edible and feed-grade fats, plasma proteins, organic fertilizers, yellow grease, and specialty casings, while also offering grease-trap collection services.
Key performance indicators that analysts typically monitor include: (1) revenue growth rate, which has averaged ~6% YoY over the past three years driven by expanding demand for sustainable protein and renewable fuel feedstocks; (2) adjusted EBITDA margin, historically around 12-13%, reflecting the capital-intensive nature of processing but also the high-value specialty product mix; and (3) free cash flow conversion, which has consistently exceeded 80% of EBITDA, supporting dividend payouts and strategic acquisitions. The sector’s growth is further propelled by regulatory pressure to divert waste from landfills and increasing consumer preference for “up-cycled” ingredients, which together act as tailwinds for DAR’s volume and pricing power.
Assuming current commodity price trends and the continued rollout of low-carbon fuel mandates, DAR’s diversified feedstock base should mitigate raw-material cost volatility, but a slowdown in the animal-protein market or stricter animal-by-product regulations could materially impact margins-analysts should watch USDA protein demand data and EPA waste-to-energy policies for early signals. For a deeper dive into DAR’s valuation nuances and scenario analysis, a quick look at ValueRay’s analyst toolkit can help surface the most relevant metrics.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 107.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.13 > 1.0 |
| NWC/Revenue: 8.43% < 20% (prev 7.35%; Δ 1.08% < -1%) |
| CFO/TA 0.07 > 3% & CFO 773.5m > Net Income 107.8m |
| Net Debt (4.25b) to EBITDA (810.2m): 5.24 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (159.9m) vs 12m ago -0.65% < -2% |
| Gross Margin: 21.46% > 18% (prev 0.23%; Δ 2122 % > 0.5%) |
| Asset Turnover: 55.59% > 50% (prev 55.91%; Δ -0.32% > 0%) |
| Interest Coverage Ratio: 1.41 > 6 (EBITDA TTM 810.2m / Interest Expense TTM 221.7m) |
Altman Z'' 2.44
| A: 0.05 (Total Current Assets 1.50b - Total Current Liabilities 1.01b) / Total Assets 10.45b |
| B: 0.38 (Retained Earnings 4.02b / Total Assets 10.45b) |
| C: 0.03 (EBIT TTM 313.1m / Avg Total Assets 10.51b) |
| D: 0.65 (Book Value of Equity 3.68b / Total Liabilities 5.68b) |
| Altman-Z'' Score: 2.44 = A |
Beneish M -2.97
| DSRI: 1.06 (Receivables 644.1m/616.7m, Revenue 5.84b/5.91b) |
| GMI: 1.09 (GM 21.46% / 23.35%) |
| AQI: 1.00 (AQ_t 0.57 / AQ_t-1 0.57) |
| SGI: 0.99 (Revenue 5.84b / 5.91b) |
| TATA: -0.06 (NI 107.8m - CFO 773.5m) / TA 10.45b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of DAR shares?
Over the past week, the price has changed by +1.80%, over one month by +25.82%, over three months by +47.40% and over the past year by +21.72%.
Is DAR a buy, sell or hold?
- StrongBuy: 8
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DAR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.8 | 5.3% |
| Analysts Target Price | 50.8 | 5.3% |
| ValueRay Target Price | 50.9 | 5.5% |
DAR Fundamental Data Overview February 07, 2026
P/E Forward = 14.4509
P/S = 1.2785
P/B = 1.618
P/EG = 14.47
Revenue TTM = 5.84b USD
EBIT TTM = 313.1m USD
EBITDA TTM = 810.2m USD
Long Term Debt = 4.03b USD (from longTermDebt, last quarter)
Short Term Debt = 144.1m USD (from shortTermDebt, last quarter)
Debt = 4.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.25b USD (from netDebt column, last quarter)
Enterprise Value = 11.72b USD (7.47b + Debt 4.34b - CCE 91.5m)
Interest Coverage Ratio = 1.41 (Ebit TTM 313.1m / Interest Expense TTM 221.7m)
EV/FCF = 24.62x (Enterprise Value 11.72b / FCF TTM 476.1m)
FCF Yield = 4.06% (FCF TTM 476.1m / Enterprise Value 11.72b)
FCF Margin = 8.15% (FCF TTM 476.1m / Revenue TTM 5.84b)
Net Margin = 1.84% (Net Income TTM 107.8m / Revenue TTM 5.84b)
Gross Margin = 21.46% ((Revenue TTM 5.84b - Cost of Revenue TTM 4.59b) / Revenue TTM)
Gross Margin QoQ = 16.81% (prev 23.35%)
Tobins Q-Ratio = 1.12 (Enterprise Value 11.72b / Total Assets 10.45b)
Interest Expense / Debt = 1.31% (Interest Expense 56.9m / Debt 4.34b)
Taxrate = 21.0% (US default 21%)
NOPAT = 247.3m (EBIT 313.1m * (1 - 21.00%))
Current Ratio = 1.49 (Total Current Assets 1.50b / Total Current Liabilities 1.01b)
Debt / Equity = 0.93 (Debt 4.34b / totalStockholderEquity, last quarter 4.69b)
Debt / EBITDA = 5.24 (Net Debt 4.25b / EBITDA 810.2m)
Debt / FCF = 8.92 (Net Debt 4.25b / FCF TTM 476.1m)
Total Stockholder Equity = 4.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.03% (Net Income 107.8m / Total Assets 10.45b)
RoE = 2.43% (Net Income TTM 107.8m / Total Stockholder Equity 4.44b)
RoCE = 3.70% (EBIT 313.1m / Capital Employed (Equity 4.44b + L.T.Debt 4.03b))
RoIC = 2.89% (NOPAT 247.3m / Invested Capital 8.54b)
WACC = 6.34% (E(7.47b)/V(11.81b) * Re(9.42%) + D(4.34b)/V(11.81b) * Rd(1.31%) * (1-Tc(0.21)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.62%
[DCF Debug] Terminal Value 84.78% ; FCFF base≈472.8m ; Y1≈483.5m ; Y5≈535.6m
Fair Price DCF = 61.02 (EV 13.90b - Net Debt 4.25b = Equity 9.65b / Shares 158.2m; r=6.34% [WACC]; 5y FCF grow 2.15% → 2.90% )
EPS Correlation: -89.03 | EPS CAGR: -38.54% | SUE: -1.85 | # QB: 0
Revenue Correlation: -22.17 | Revenue CAGR: 4.84% | SUE: 1.10 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.090 | Revisions Net=+1 | Analysts=5
EPS next Year (2026-12-31): EPS=2.41 | Chg30d=-0.087 | Revisions Net=+0 | Growth EPS=+471.0% | Growth Revenue=+4.7%